CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 87.63%76.12M | 30.31%820.33M | ---- | --261.33M | --40.57M | 34.66%629.55M | ---- | 19.23%467.5M | --188.43M | -0.52%392.11M |
Cash received relating to other operating activities | -51.33%11.04M | 48.14%48.91M | ---- | --30.59M | --22.69M | 65.09%33.02M | ---- | 61.22%20M | --16.87M | -73.40%12.41M |
Cash inflows from operating activities | 37.78%87.17M | 31.19%869.25M | ---- | --291.92M | --63.27M | 35.91%662.57M | ---- | 20.52%487.5M | --205.31M | -8.29%404.51M |
Goods services cash paid | -27.28%84.29M | 40.67%453.3M | ---- | --221.81M | --115.92M | 71.52%322.24M | ---- | -8.76%187.88M | --107.3M | -6.94%205.93M |
Staff behalf paid | 53.58%56M | 15.99%194.14M | ---- | --81.35M | --36.46M | 27.72%167.38M | ---- | 0.69%131.05M | --51.49M | -1.17%130.15M |
All taxes paid | 42.03%19.56M | 21.96%95.24M | ---- | --39.58M | --13.77M | 67.53%78.09M | ---- | -48.23%46.61M | --12.67M | 122.65%90.03M |
Cash paid relating to other operating activities | 38.69%34.15M | 97.43%89.7M | ---- | --42.36M | --24.62M | -15.54%45.43M | ---- | 6.06%53.8M | --15.48M | -56.59%50.72M |
Cash outflows from operating activities | 1.69%194M | 35.76%832.38M | ---- | --385.1M | --190.77M | 46.22%613.14M | ---- | -12.06%419.33M | --186.94M | -6.55%476.83M |
Net cash flows from operating activities | 16.21%-106.83M | -25.40%36.87M | -82.33%-86.09M | ---93.17M | ---127.5M | -27.50%49.42M | ---47.22M | 194.27%68.17M | --18.37M | -4.53%-72.32M |
Investing cash flow | ||||||||||
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -93.38%141.83K | ---- | --141.83K | ---- | 25,111.29%2.14M | ---- | -96.63%8.5K | --8.5K | --252.51K |
Cash received relating to other investing activities | ---- | 1,429.15%11.82M | ---- | --11.82M | --6.81M | --773K | ---- | ---- | ---- | ---- |
Cash inflows from investing activities | ---- | 310.23%11.96M | ---- | --11.96M | --6.81M | 34,205.41%2.92M | ---- | -96.63%8.5K | --8.5K | -99.73%252.51K |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -22.59%23.64M | -5.48%88.91M | ---- | --42.15M | --30.54M | 45.96%94.07M | ---- | 267.23%64.45M | --12.49M | -56.00%17.55M |
Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.33%30M |
Cash paid relating to other investing activities | ---- | 1,685.25%13.8M | ---- | --11.8M | --6.8M | --773K | ---- | ---- | ---- | -98.91%40K |
Cash outflows from investing activities | -36.68%23.64M | 8.30%102.71M | ---- | --53.95M | --37.34M | 47.16%94.84M | ---- | 35.42%64.45M | --12.49M | -57.60%47.59M |
Net cash flows from investing activities | 22.56%-23.64M | 1.28%-90.75M | ---- | ---41.99M | ---30.53M | -42.65%-91.92M | ---- | -36.13%-64.44M | ---12.48M | -158.90%-47.34M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --297.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -87.56%15M |
Cash from borrowing | 148.70%100.24M | 41.01%290.3M | ---- | --109.66M | --40.3M | 34.42%205.87M | ---- | -28.07%153.16M | --36.87M | 59.29%212.91M |
Cash inflows from financing activities | 886.71%397.68M | 41.01%290.3M | ---- | --109.66M | --40.3M | 34.42%205.87M | ---- | -32.80%153.16M | --36.87M | -21.41%227.91M |
Borrowing repayment | 548.46%69.85M | 163.13%225.64M | ---- | --100.98M | --10.77M | 48.10%85.75M | ---- | -22.80%57.9M | --32.9M | -53.35%75M |
Dividend interest payment | 36.66%1.73M | 101.03%6.49M | ---- | --2.89M | --1.27M | 121.83%3.23M | ---- | -71.92%1.46M | --628.46K | -19.89%5.18M |
Cash payments relating to other financing activities | 1,707.03%16.88M | -18.67%10.37M | ---- | --5.01M | --934.18K | -15.18%12.76M | ---- | -35.17%15.04M | --9.75M | -57.22%23.2M |
Cash outflows from financing activities | 581.88%88.47M | 138.37%242.5M | ---- | --108.88M | --12.97M | 36.75%101.74M | ---- | -28.04%74.39M | --43.28M | -53.32%103.38M |
Net cash flows from financing activities | 1,031.42%309.21M | -54.10%47.79M | ---- | --786.5K | --27.33M | 32.21%104.13M | ---- | -36.75%78.76M | ---6.41M | 81.66%124.53M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---51.6 | ---- | ---- | ---- | ---- |
Net increase in cash and cash equivalents | 236.75%178.74M | -109.88%-6.09M | ---- | ---134.37M | ---130.71M | -25.29%61.63M | ---- | 1,591.08%82.49M | ---524.99K | 125.79%4.88M |
Add:Begin period cash and cash equivalents | -3.79%154.71M | 62.15%160.8M | ---- | --160.8M | --160.8M | 494.81%99.17M | ---- | 41.36%16.67M | --16.67M | -61.60%11.79M |
End period cash equivalent | 1,007.99%333.45M | -3.79%154.71M | ---- | --26.43M | --30.1M | 62.15%160.8M | ---- | 494.81%99.17M | --16.15M | 41.36%16.67M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | Unqualified opinion | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.